Randomized Placebo-Controlled Trial Evaluating the Ophthalmic Safety of Single-Dose Tafenoquine in Healthy Volunteers.
Saved in:
| Title: | Randomized Placebo-Controlled Trial Evaluating the Ophthalmic Safety of Single-Dose Tafenoquine in Healthy Volunteers. |
|---|---|
| Authors: | Ackert J; Clinical Research and Development, GlaxoSmithKline, Collegeville, PA, USA., Mohamed K; Quantitative Sciences, GlaxoSmithKline Research and Development, Stockley Park West, Uxbridge, Middlesex, UK., Slakter JS; Digital Angiography Reading Center (DARC), Great Neck, New York, NY, USA., El-Harazi S; Lugene Eye Institute, Glendale, CA, USA., Berni A; Global Health, GlaxoSmithKline Research and Development Ltd., Stockley Park West, Uxbridge, Middlesex, UB11 1BT, UK., Gevorkyan H; California Clinical Trials Medical Group in affiliation with Parexel International, Glendale, CA, USA., Hardaker E; Safety Evaluation and Risk Management, GlaxoSmithKline Research and Development, Stockley Park West, Uxbridge, Middlesex, UK., Hussaini A; PAREXEL, Harbor Hospital, Baltimore, Baltimore, MD, USA., Jones SW; Safety Evaluation and Risk Management, GlaxoSmithKline Research and Development, Stockley Park West, Uxbridge, Middlesex, UK., Koh GCKW; Global Health, GlaxoSmithKline Research and Development Ltd., Stockley Park West, Uxbridge, Middlesex, UB11 1BT, UK., Patel J; Clinical Data Management, GlaxoSmithKline Research and Development, Collegeville, PA, USA., Rasmussen S; IQVIA, Overland Park, KS, USA., Kelly DS; Global Clinical Safety and Pharmacovigilance, GlaxoSmithKline, Collegeville, PA, USA., Barañano DE; Retina Specialists, Baltimore, MD, USA., Thompson JT; Retina Specialists, Baltimore, MD, USA., Warren KA; IQVIA, Overland Park, KS, USA., Sergott RC; Neuro-Ophthalmology Service, Wills Eye Hospital, Philadelphia, PA, USA., Tonkyn J; GSK Medicines Research Centre, GlaxoSmithKline, Stevenage, Hertfordshire, UK., Wolstenholme A; GlaxoSmithKline, Upper Providence, Collegeville, PA, USA., Coleman H; Digital Angiography Reading Center (DARC), Great Neck, New York, NY, USA., Yuan A; Digital Angiography Reading Center (DARC), Great Neck, New York, NY, USA., Duparc S; Research and Development, Medicines for Malaria Venture, Geneva, Switzerland., Green JA; Global Health, GlaxoSmithKline Research and Development Ltd., Stockley Park West, Uxbridge, Middlesex, UB11 1BT, UK. justin.a.green@gsk.com. |
| Source: | Drug safety [Drug Saf] 2019 Sep; Vol. 42 (9), pp. 1103-1114. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1179-1942 |
|---|---|
| DOI: | 10.1007/s40264-019-00839-w |
